Bribery, Fraud & Tax Evasion
Kyle "Dusty" Foggo, the former No. 3 official in the CIA, pleaded guilty yesterday to fraudulently steering intelligence contracts to his lifelong friend, former Poway defense contractor Brent Wilkes.
A new study, issued by scientists at the Freeman Spogli institute at Stanford university in California, that suggests that organic food has no medical or health values is deeply flawed, say outraged activists.
A former banker at UBS AG pleaded guilty in federal court to helping a billionaire client evade taxes by hiding $200 million in assets in offshore accounts, in a move expected to aid U.S. prosecutors in their probe of the Swiss banking giant.
A procedure designed to alert the Food and Drug Administration to scientific and safety issues is getting a hard look from members of Congress, who say they are concerned that it may be getting subverted by the brand-name drug industry.
A huge state-owned Chinese pharmaceutical company that exports to dozens of countries, including the United States, is at the center of a nationwide drug scandal after nearly 200 Chinese cancer patients were paralyzed or otherwise harmed last summer by contaminated leukemia drugs.
Over the 4th of July weekend, stories about Bush's questionable behavior as an executive of Harken Energy became grist for the weekend talk shows. With today's Wall Street policy speech looming, the President and his men hoped that addressing the inevitable press questions about Harken the day before would take the steam out of the issue today.
Free trade advocates and multinational corporations are pinning their hopes on Robert Zoellick, the United States trade representative, as negotiators from around the two continents gather in Miami for the Free Trade of the Americas talks.
The U.S. State Department on Thursday suspended the international export activities of AEY Inc., a Miami Beach arms-dealing company led by a 22-year-old man whose munitions procurements for the Pentagon are under criminal investigation.
Greg Smith, a Goldman Sachs employee in London, has quit the company with a fiercely critical op-ed in the New York Times in which he accuses the Wall Street investment bank of losing its moral compass.
While overcharging for a product is not in itself illegal, misrepresenting the goods sold can be. The plaintiffs' central argument hinges on Park West's description of its appraisals.